In this single-center, case-control study, we measured the plasma levels of IL-17, IL-22, IL-23 and IL-33 in 21 cardiac arrest patients with ROSC at three time-points (baseline [within 1 h post ROSC], 2 days post ROSC and 7 days post ROSC). The gene discussed is IL22; the disease is cardiac arrest.